Patents Assigned to IGL Pharma, Inc.
  • Method of use for therapeutic bone agents
    Patent number: 11813339
    Abstract: This invention relates to radioactive, bone-seeking, pharmaceutical compositions that are administered multiple times to a patient, have a lower impurity profile, a longer shelf life, and are less expensive to prepare.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: November 14, 2023
    Assignee: IGL PHARMA, INC.
    Inventors: Jaime Simon, R. Keith Frank
  • METHOD OF USE FOR THERAPEUTIC BONE AGENTS
    Publication number: 20210138095
    Abstract: This invention relates to radioactive, bone-seeking, pharmaceutical compositions that are administered multiple times to a patient, have a lower impurity profile, a longer shelf life, and are less expensive to prepare.
    Type: Application
    Filed: February 6, 2018
    Publication date: May 13, 2021
    Applicant: IGL Pharma, Inc.
    Inventors: Jaime Simon, R. Keith Frank
  • High purity therapeutic bone agents
    Patent number: 10596277
    Abstract: This invention relates to radioactive, bone-seeking, pharmaceutical methods, compositions and formulations that have a lower impurity profile, a longer shelf life, improved availability and are less expensive to prepare. The compositions of this invention can be conveniently prepared in a timely manner resulting in improved availability and delivery of the drugs to patients.
    Type: Grant
    Filed: November 17, 2018
    Date of Patent: March 24, 2020
    Assignee: IGL Pharma, Inc.
    Inventors: Jaime Simon, R. Keith Frank, David A. Wilson
  • High purity therapeutic bone agents
    Patent number: 10172965
    Abstract: This invention relates to radioactive, bone-seeking, pharmaceutical methods, compositions and formulations that have a lower impurity profile, a longer shelf life, improved availability and are less expensive to prepare. The compositions of this invention can be conveniently prepared in a timely manner resulting in improved availability and delivery of the drugs to patients.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: January 8, 2019
    Assignee: IGL Pharma, Inc.
    Inventors: Jaime Simon, R. Keith Frank, David A. Wilson